Our Company

Kirsten joined Imperative Care in October 2017 as Vice President Strategic Development, and in early 2020 founded the company’s Patient-at-Home initiative, the development program that served as the basis for the creation of Kandu. Previously, she spent a combined nearly 15 years in the Neurovascular Division of Stryker and Boston Scientific, where she held strategic development, planning, marketing, and product management positions. Kirsten holds several patents in the fields of stroke treatment and detection, and she is the author of several peer-reviewed papers in the field of stroke and access to care.

Stefan joined Kandu in September 2022. Previously, he was a Vice President and Head of Investments at Hyundai Motor Group's Corporate Venture Capital Arm. Prior to joining Hyundai, Stefan was the Vice President of Operations and Innovation at Samsung Strategy and Innovation Center with global operational responsibility for programs in Digital Health, Internet of Things, and Autonomous Driving. Prior to that, Stefan built and led an early-stage venture investment team for Samsung Global Innovation Center. Earlier in his career, Stefan was the CFO and VP Finance for Siemens Smart Grid Applications. Stefan holds a master’s degree in business administration from Ludwig-Maximilian University of Munich.

Clayton has held growth and strategy leadership positions in early and growth-stage healthcare companies for over 20 years. With broad experience leading value-based and integrated care initiatives, Clayton now leads Kandu’s commercialization efforts which focused primarily on creating accretive strategic partnerships with payers and providers. Clayton graduated from Texas Tech University, obtained a master’s degree from Thunderbird, the American School of Global Management and his JD from SMU Dedman School of Law.

Internationally acclaimed neurologist and researcher, Tudor G. Jovin, MD, is based at Cooper University Hospital in Camden, New Jersey and presides as the Chief and Chairman of Cooper Neurological Institute. Dr. Jovin is an expert in the interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He was one of the nation's first interventional neurologists, a medical subspecialty that uses minimally invasive technologies applied from within the vessels to diagnose and treat diseases of the arteries and veins of the head, neck, and spine such as acute stroke, carotid stenosis, intracranial aneurysm, and arteriovenous malformations. In addition to his clinical experience, Dr. Jovin is known internationally for his research activities. He has served as principal investigator for several international clinical studies including REVASCAT, a randomized trial of endovascular therapy versus medical therapy for acute stroke within eight hours of symptoms onset conducted in Spain, and DAWN, a multicenter, international, randomized trial of endovascular therapy versus medical therapy in the beyond eight-hour time window. Both studies are considered landmark studies in the development of treatments for acute stroke and have been published in the New England Journal of Medicine. He is a member of the executive or steering committees for several multicenter national and international trials, and has participated as site principal investigator or co-investigator in multiple national and international trials. Additionally, he serves as editorial board member for numerous medical journals. Dr. Jovin has published more than 300 articles in peer-reviewed journals or book chapters. The consequential nature of his research is evidenced by recently published studies that have identified Dr. Jovin as the highest impact author in the neuro-interventional field. Prior to joining Cooper, Dr. Jovin was a professor of neurology and neurosurgery at the University of Pittsburgh School of Medicine and director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center (UPMC). At UPMC, he also served as the director of UPMC's Stroke Institute, one of the leading centers for stroke care, education, and research in the world.

Ramin leads the engineering, product, and design teams at Kandu, and has over 12 years of experience in digital health solutions. He is passionate about working closely with patients and clinicians alike to uncover challenges, and design helpful and intuitive digital solutions for people living with stroke.

With over 15 years of marketing experience in health technology for stroke care, Jen is passionate about patient and care partner support after becoming a care partner for her father who suffered from Parkinson’s Disease. She loves storytelling and shining a light on stroke survivors and their experiences.

Sean has extensive professional experience ranging from acute clinical practice to healthcare entrepreneurship. Data analysis and commercial viability drive his work, helping demystify intricacies to enhance both healthcare delivery and business operations. His personal mission is to revolutionize healthcare by integrating cutting-edge technology with human-centric care, ensuring accessibility, efficiency, and excellence. His journey has been characterized by a relentless pursuit of innovation and efficiency. He seeks opportunities to serve as an innovation catalyst, working with forward-thinking organizations and individuals to develop solutions that truly make a difference. Through perseverance, creativity, and a priority-driven focus on value, he aspires to lead the next wave of breakthroughs that fundamentally reshape how health is defined, delivered, and experienced.